APA (7th ed.) Citation

Anty, R., Iannelli, A., Patouraux, S., Bonnafous, S., Lavallard, V. J., Senni‐Buratti, M., . . . Tran, A. (2010). A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients R. Anty et al. Nice Model to diagnose NASH in morbid obesity. Alimentary Pharmacology & Therapeutics, 32(11/12), 1315. https://doi.org/10.1111/j.1365-2036.2010.04480.x

Chicago Style (17th ed.) Citation

Anty, R., et al. "A New Composite Model Including Metabolic Syndrome, Alanine Aminotransferase and Cytokeratin-18 for the Diagnosis of Non-alcoholic Steatohepatitis in Morbidly Obese Patients R. Anty Et Al. Nice Model to Diagnose NASH in Morbid Obesity." Alimentary Pharmacology & Therapeutics 32, no. 11/12 (2010): 1315. https://doi.org/10.1111/j.1365-2036.2010.04480.x.

MLA (9th ed.) Citation

Anty, R., et al. "A New Composite Model Including Metabolic Syndrome, Alanine Aminotransferase and Cytokeratin-18 for the Diagnosis of Non-alcoholic Steatohepatitis in Morbidly Obese Patients R. Anty Et Al. Nice Model to Diagnose NASH in Morbid Obesity." Alimentary Pharmacology & Therapeutics, vol. 32, no. 11/12, 2010, p. 1315, https://doi.org/10.1111/j.1365-2036.2010.04480.x.